FIELD: medicine.
SUBSTANCE: invention proposes compositions, which contain stabilised exendin-4(1-39) and allied compounds. Invention describes stabilised agonists of exendin-4, which contain at least one modified amino-acid remainder, in particular in position Asn28 of exendin-4(1-39) molecule.
EFFECT: increased efficiency of application in treatment of diseases.
15 cl, 9 dwg, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
OPERATION MEMBER AND MECHANISM FOR DRUG DELIVERY DEVICE, AND DRUG DELIVERY DEVICE | 2014 |
|
RU2676513C1 |
INJECTION DEVICE | 2020 |
|
RU2818165C2 |
INJECTION DEVICE | 2014 |
|
RU2675685C2 |
PENCIL TYPE INJECTOR | 2013 |
|
RU2643081C2 |
SYNTHESIS OF LIXISENATIDE WITH CAPPING | 2019 |
|
RU2782772C2 |
AUTOMATIC INJECTION DEVICE | 2014 |
|
RU2675683C2 |
PISTON FOR CARTRIDGE AND PISTON ROD FOR DEVICE FOR MEDICATION DELIVERY | 2010 |
|
RU2552887C2 |
DRUG DELIVERY DEVICE AND ASSEMBLY METHOD FOR DRUG DELIVERY DEVICE | 2019 |
|
RU2794029C2 |
DRUG DELIVERY DEVICE FOR INTRODUCTION OF PRESET DRUG DOSE | 2012 |
|
RU2603289C2 |
DRUG DELIVERY DEVICE AND CARTRIDGE HOLDER FOR DRUG DELIVERY DEVICE | 2012 |
|
RU2605422C2 |
Authors
Dates
2009-12-20—Published
2003-10-02—Filed